T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Bruker
BRKR
$8.69B
| $559M | 0.12% |
27,403,720
+1,089,480
| +4% | +$22M |
|
202
Idexx Laboratories
IDXX
$46.2B
| $555M | 0.11% |
8,650,066
+84,438
| +1% | +$5.85M |
|
203
Berkshire Hathaway Class B
BRK.B
$1.11T
| $552M | 0.11% |
4,058,271
+21,424
| +0.5% | +$3.06M |
|
204
Emerson Electric
EMR
$91.7B
| $549M | 0.11% |
9,909,661
-333,342
| -3% | -$19.6M |
|
205
McDonald's
MCD
$194B
| $548M | 0.11% |
5,765,275
-1,759,377
| -23% | -$170M |
|
206
Global Payments
GPN
$22.7B
| $547M | 0.11% |
10,582,856
+60,704
| +0.6% | +$3.11M |
|
207
Keysight
KEYS
$58.7B
| $547M | 0.11% |
17,542,964
+1,268,496
| +8% | +$43.4M |
|
208
Sysco
SYY
$40.3B
| $542M | 0.11% |
15,025,710
-3,725,015
| -20% | -$139M |
|
|
CA
209
DELISTED
CA, Inc.
CA
| $540M | 0.11% |
18,424,254
+2,530,105
| +16% | +$78.6M |
|
210
Progressive
PGR
$123B
| $538M | 0.11% |
19,324,029
+948,310
| +5% | +$25.9M |
|
211
Factset
FDS
$10.1B
| $537M | 0.11% |
3,303,760
-402,570
| -11% | -$65.4M |
|
|
TWC
212
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $536M | 0.11% |
3,006,664
-616,570
| -17% | -$102M |
|
213
American Electric Power
AEP
$67.3B
| $535M | 0.11% |
10,107,714
+1,346,644
| +15% | +$74.5M |
|
214
Cboe Global Markets
CBOE
$29.5B
| $527M | 0.11% |
9,206,278
+95,491
| +1% | +$5.51M |
|
215
Blackrock
BLK
$178B
| $526M | 0.11% |
1,521,575
-24,098
| -2% | -$8.78M |
|
|
APC
216
DELISTED
Anadarko Petroleum
APC
| $525M | 0.11% |
6,730,566
-146,918
| -2% | -$12.7M |
|
217
3M
MMM
$94.4B
| $522M | 0.11% |
4,044,438
-2,531,040
| -38% | -$339M |
|
218
Jones Lang LaSalle
JLL
$16.7B
| $521M | 0.11% |
3,049,228
+30,108
| +1% | +$5.08M |
|
|
RDS.B
219
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $521M | 0.11% |
9,086,661
+50,919
| +0.6% | +$3.15M |
|
|
CTLT
220
DELISTED
CATALENT, INC.
CTLT
| $521M | 0.11% |
17,753,208
+62,410
| +0.4% | +$1.88M |
|
221
Gartner
IT
$11.8B
| $520M | 0.11% |
6,060,594
-838,530
| -12% | -$71.9M |
|
222
Micron Technology
MU
$981B
| $517M | 0.11% |
27,436,013
+9,421,404
| +52% | +$251M |
|
|
FEIC
223
DELISTED
FEI COMPANY
FEIC
| $516M | 0.11% |
6,217,053
-19,618
| -0.3% | -$1.56M |
|
224
Dentsply Sirona
XRAY
$2.31B
| $512M | 0.11% |
9,939,393
-834,313
| -8% | -$43.2M |
|
225
Palo Alto Networks
PANW
$313B
| $511M | 0.11% |
17,552,628
-2,177,256
| -11% | -$58.1M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.